Cargando…

Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature

RATIONALE: Cisplatin monotherapy-induced cardiotoxicity is rare, and the prevalence remains unknown. It's extremely important to stop cisplatin when cardiotoxicity is considered. PATIENT CONCERNS: A 53-year-old woman developed cervical cancer. She was administered cisplatin (37 mg/m(2)/wk) for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yang, Sun, Bin, Zhao, Bin, Mei, Dan, Gu, Qing, Tian, Zhuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314747/ https://www.ncbi.nlm.nih.gov/pubmed/30593170 http://dx.doi.org/10.1097/MD.0000000000013807

Ejemplares similares

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Lakhani, Ishan, et al.
Publicado: (2019)

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction
por: Gastelurrutia, Paloma, et al.
Publicado: (2018)

Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2019)

Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction
por: Nadruz, Wilson, et al.
Publicado: (2017)

Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Kitai, Takeshi, et al.
Publicado: (2020)

Racial differences of heart failure with midrange ejection fraction (HFmrEF): a large urban centre-based retrospective cohort study in the USA
por: Li, Dan Leslie, et al.
Publicado: (2019)

Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis
por: Lebedev, D. A., et al.
Publicado: (2020)

Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
por: Ye, Fanhao, et al.
Publicado: (2022)

The Safety of The Directly Acting Antiviral Treatment For Hepatitis C Virus According To The Egyptian National Program Protocol In Patients With Midrange Ejection Fraction
por: Alaarag, Ahmed Farouk, et al.
Publicado: (2021)

Surgical treatment of patients with aortic valve disease complicated with moderate functional mitral regurgitation and heart failure with midrange ejection fraction: a cohort study
por: Zhao, Wei, et al.
Publicado: (2022)

Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction
por: Popovic, Dejana, et al.
Publicado: (2020)

Follow‐up after hemodynamically not tolerated ventricular tachycardia in patients with midrange reduced to normal ejection fraction: A retrospective single‐centre case series
por: Groeneveld, Sanne A., et al.
Publicado: (2020)

Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
por: Choi, Ki Hong, et al.
Publicado: (2018)

Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania
por: Bordejevic, Diana Aurora, et al.
Publicado: (2021)

The effect of angiotensin-converting enzyme inhibitors on clinical outcomes in patients with ischemic cardiomyopathy and midrange ejection fraction: a post hoc subgroup analysis from the PEACE trial
por: Alzahrani, Talal, et al.
Publicado: (2018)

Magnetostriction Enhancement in Midrange Modulus Magnetorheological Elastomers for Sensor Applications
por: Tasin, Muhammad Asyraf, et al.
Publicado: (2023)

Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients
por: Nousiainen, T, et al.
Publicado: (2002)

Use of the Left Ventricular Internal Dimension at End-Diastole and the E-Point Septal Separation Ratio in the Prediction of the Left Ventricular Systolic Function in Patients with Midrange and Reduced Ejection Fractions: A Pilot Study
por: Cosansu, Kahraman, et al.
Publicado: (2019)

Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
por: Posch, Florian, et al.
Publicado: (2022)

Role of Diabetes Mellitus in Acute Coronary Syndrome Patients with Heart Failure and Midrange Ejection Fraction Who Have Undergone Percutaneous Coronary Intervention: A 3-Year Case-Series Follow-Up Retrospective Study
por: Li, Lieyou, et al.
Publicado: (2021)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020)

Wogonin Alleviates Cisplatin-induced Cardiotoxicity in Mice Via Inhibiting Gasdermin D-mediated Pyroptosis
por: Xu, Jiajun, et al.
Publicado: (2021)

Geodynamically corrected Pliocene shoreline elevations in Australia consistent with midrange projections of Antarctic ice loss
por: Richards, Fred D., et al.
Publicado: (2023)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Cardiovascular magnetic resonance can detect occult anthracycline cardiotoxicity in adolescents and young adults cancer survivors with normal ejection fraction
por: Vieira, Miguel S, et al.
Publicado: (2016)

Capecitabine-induced cardiotoxicity: case report and review of the literature
por: Ang, C., et al.
Publicado: (2010)

Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity
por: Bayrak, Serdar, et al.
Publicado: (2020)

Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry
por: Kitakata, Hiroki, et al.
Publicado: (2020)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
por: Zhao, Xiaopeng, et al.
Publicado: (2023)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

Anthracycline-induced cardiotoxicity: A case report and review of literature
por: Chong, Esther G, et al.
Publicado: (2021)

Increased index of microcirculatory resistance in older patients with heart failure with preserved ejection fraction
por: Xu, Zhuo, et al.
Publicado: (2018)

Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis
por: Qian, Peng, et al.
Publicado: (2018)

Melatonin attenuates doxorubicin‐induced cardiotoxicity through preservation of YAP expression
por: Li, Hai‐ru, et al.
Publicado: (2020)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tj3trrl33tual9g48n24t6cva0